Admission glucose, HbA1c levels and inflammatory cytokines in patients with acute ST-elevation myocardial infarction
- PMID: 39962379
- PMCID: PMC11834255
- DOI: 10.1186/s12014-025-09530-y
Admission glucose, HbA1c levels and inflammatory cytokines in patients with acute ST-elevation myocardial infarction
Abstract
Background: To investigate the association between admission glucose and HbA1c values and inflammatory plasma proteins in hospitalized patients with acute ST-elevation myocardial infarction (STEMI).
Methods: This analysis was based on 345 STEMI patients recorded by the population-based Myocardial Infarction Registry Augsburg between 2009 and 2013. Using the OLINK inflammatory panel, a total of 92 protein biomarkers were measured in arterial blood samples, which were obtained within the scope of cardiac catheterization immediately after admission. The associations between admission glucose and HbA1c levels and the 92 protein markers were investigated using multivariable linear regression models.
Results: Admission glucose showed significantly positive associations with the inflammatory markers IL-10, IL-8, IL-6, FGF-21, IL-7, ST1A1, MCP-1, 4E-BP1, SIRT2, STAMBP and IL-18R1 after Bonferroni adjustment. HbA1c values were only significantly associated with IL-18R1. In stratified analyses, admission glucose was not significantly associated with any plasma protein in the diabetes subgroup, while there were several protein markers that showed significantly positive associations with admission glucose in STEMI patients without known diabetes, namely IL-10, CCL20, IL-8, MCP-1 and IL-6.
Conclusions: Admission glucose in patients hospitalized due to an acute STEMI seems to be related to an inflammatory and immune-related response, expressed by an increase in inflammation-related plasma proteins in particular in non-diabetic patients with stress hyperglycemia. The present results may open new avenues for the development of biomarkers suitable as potential diagnostic or prognostic clinical markers.
Keywords: Admission blood glucose; Cytokines; Glucose metabolism; HbA1c; Inflammatory plasma proteins; Myocardial infarction.
© 2025. The Author(s).
Conflict of interest statement
Declarations. Ethics approval and consent to participate: Data collection of the Augsburg MI registry has been approved by the ethics committee of the Bavarian Medical Association (Bayerische Landesärztekammer) and the study was performed in accordance with the Declaration of Helsinki. All study participants have given written informed consent. Consent for publication: Not applicable. Competing interests: The authors declare no competing interests.
Figures



References
-
- Leonidou L, Mouzaki A, Michalaki M, DeLastic AL, Kyriazopoulou V, Bassaris HP, Gogos CA. Cytokine production and hospital mortality in patients with sepsis-induced stress hyperglycemia. J Infect. 2007;55:340–6. 10.1016/j.jinf.2007.05.177 - PubMed
-
- McCowen KC, Malhotra A, Bistrian BR. Stress-induced hyperglycemia. Crit Care Clin. 2001;17:107–24. 10.1016/s0749-0704(05)70154-8 - PubMed
-
- Marik PE, Raghavan M. Stress-hyperglycemia, insulin and immunomodulation in sepsis. Intensive Care Med. 2004;30:748–56. 10.1007/s00134-004-2167-y - PubMed
-
- Stentz FB, Umpierrez GE, Cuervo R, Kitabchi AE. Proinflammatory cytokines, markers of cardiovascular risks, oxidative stress, and lipid peroxidation in patients with hyperglycemic crises. Diabetes. 2004;53:2079–86. 10.2337/diabetes.53.8.2079 - PubMed
-
- Esposito K, Nappo F, Marfella R, Giugliano G, Giugliano F, Ciotola M, et al. Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans: role of oxidative stress. Circulation. 2002;106:2067–72. 10.1161/01.cir.0000034509.14906.ae - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous